Models of type 1 (autoimmune) diabetes
Drug Discovery Today: Disease Models, ISSN: 1740-6757, Vol: 1, Issue: 4, Page: 451-455
2004
- 5Citations
- 18Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Review Description
Type 1 (autoimmune) diabetes is caused by T-cell autoreactivity resulting in destruction of the insulin-producing pancreatic islet β cells. Its aetiology involves complex interactions between multiple genetic and environmental factors, its pathogenesis involves interactions between many leukocyte subsets and their associated cytokines and its complications affect nearly every organ in the body. Modelling the disease is, therefore, the subject of much effort and surprising ingenuity. In this article, we review established and emerging models of the disease and give an indication of their use for different types of study.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1740675704000647; http://dx.doi.org/10.1016/j.ddmod.2004.11.012; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=23744478682&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S1740675704000647; https://dx.doi.org/10.1016/j.ddmod.2004.11.012
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know